| dc.description | L. Pezzia,b,∗, M. Dialloc, M.G. Rosa-Freitasd, A. Vega-Ruae, L.F.P. Ngf, S. Boyerg, J.F. Drexlerh,i, N. Vasilakisj, R. Lourenco-de-Oliveirad, S.C. Weaverk, A. Kohll, X. de Lamballeriea, A.-B. Faillouxm, on behalf of GloPID-R chikungunya, o'nyong-nyong and Mayaro virus Working Group (P. Brasiln, M. Buscho, M.S. Diamondp,q,r, M.A. Drebots, P. Galliant, T. Jaenischu, A.D. LaBeaudv, M. Lecuitw, J. Neytsx, C.B. Reuskeny,z, G.S. Ribeiroaa, M. Riosab, A.J. Rodriguez-Moralesac, A. Sallc, G. Simmonsad, F. Simonae, A.M. Siqueiran).a Unité des Virus Émergents (UVE: Aix-arseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France
b EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France c Unité d'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal d Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil e Laboratory of Vector Control Research, Environment and Health Unit, Institut Pasteur de la Guadeloupe, Guadeloupe f Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore g Medical Entomology Platform, Institut Pasteur du Cambodge, Phnom Penh, Cambodia h Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, 10117, Berlin, Germany i German Centre for Infection Research (DZIF), Germany j Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, alveston, USA k Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA l MRC-University of Glasgow Centre for Virus Research, Glasgow, UK m Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France c Unité d'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senega
n Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
o Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA
p Department of Medicine, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of
Medicine, St. Louis, USA
q Department of Molecular Microbiology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA r Department of Pathology and Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington
University School of Medicine, St. Louis, USA s Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada t Établissement Français du Sang Alpes Méditerranée, Marseille, France u Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany v Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA w Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France x KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium y Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands z Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands aa Gonçalo Moniz Institute, Oswaldo Cruz Foundation, and Federal University of Bahia, Salvador, Brazil ab Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and
Research, U.S. Food and Drug Administration, Silver Spring, USA ac Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia ad Blood Systems Research Institute, San Francisco, USA, and Department of Pathology and Laboratory Medicine, University of California, San Francisco, San Francisco, USA ae Laveran Military Teaching Hospital, Marseille, France. | |
